Evidence map›Paper›PMID 32842092›Full record

ArticleRetina (Philadelphia, Pa.)2020

Reply.

Frank G Holz, Marta S Figueroa, Francesco Bandello, Yit Yang, Masahito Ohji, Hong Dai, Halina Wykrota, Sanjay Sharma, Cornelia Dunger-Baldauf, Sue Lacey and 3 more

Abstract readComment
PubMed Publisher
In one paragraph

Article in Retina (Philadelphia, Pa.), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Frank G HolzDepartment of Ophthalmology, University of Bonn, Bonn, Germany.
Marta S FigueroaDepartment of Ophthalmology, Ramon y Cajal University Hospital, Madrid, Spain.
Francesco BandelloDepartment of Ophthalmology, University Vita-Salute, Scientific Institute San Raffaele, Milan, Italy.
Yit YangDepartment of Ophthalmology, Wolverhampton Eye Infirmary, Wolverhampton, United Kingdom.
Masahito OhjiDepartment of Ophthalmology, Shiga University of Medical Science, Otsu, Shiga, Japan.
Hong DaiDepartment of Ophthalmology, Beijing Hospital, National Center of Gerontology, Beijing, China.
Halina WykrotaDepartment of Ophthalmology, I Kliniki Okulistyki Slaskiej Akademii Medycznej w Katowicach, Katowice, Poland.
Sanjay SharmaDepartment of Ophthalmology and Epidemiology, Queen's University, Kingston, Ontario, Canada.
Cornelia Dunger-BaldaufDepartment of Ophthalmology, Novartis Pharma AG, Basel, Switzerland.
Sue LaceyDepartment of Ophthalmology, Novartis Pharmaceuticals UK Limited, Surrey, Frimley, Camberley, United Kingdom.
Wayne MacfaddenDepartment of Ophthalmology, Novartis Pharma AG, Basel, Switzerland.
Paul MitchellDepartment of Ophthalmology, Centre for Vision Research, Westmead Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia.
all the LUMINOUS study investigators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Macular DegenerationHumansRanibizumabRanibizumab

Identifiers

PMID32842092

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.